Maraviroc, marketed under the brand name Selzentry, is a medication used in the treatment of HIV infection. It belongs to a class of drugs known as CCR5 antagonists, which work by blocking the CCR5 receptor on certain immune cells, preventing the virus from entering and infecting these cells.

Selzentry is typically prescribed for patients who have already been treated with other HIV medications and have developed resistance to them. It is often used in combination with other antiretroviral drugs to effectively suppress the virus and improve the patient’s immune function.

As with any medication, there are potential side effects associated with Selzentry. Common side effects may include diarrhea, nausea, headache, and dizziness. More serious side effects such as liver problems or allergic reactions are rare but can occur. It is important for patients to discuss any concerns or symptoms with their healthcare provider.

It is crucial for patients taking Selzentry to adhere to their prescribed regimen and follow up with their healthcare provider regularly. Monitoring of viral load and CD4 cell count is essential to assess the effectiveness of the treatment and make any necessary adjustments.

Overall, Selzentry has been shown to be an effective and well-tolerated medication for the treatment of HIV infection. It is important for patients to work closely with their healthcare team to ensure the best possible outcomes and maintain their overall health and well-being.